GW815SF

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GW815SF, covering 2013-04-15 to 2019-02-01. Get the full timeline:

Most recent: Clinical Trial Update: GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) [Phase 3]